SIGRIMA 420MG

About

Imatinib is a potent tyrosine kinase inhibitor that selectively targets the Bcr-Abl fusion protein, a constitutively active tyrosine kinase central to the pathogenesis of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It also inhibits other tyrosine kinases, including c-KIT and PDGF-R, making it effective in treating gastrointestinal stromal tumors (GIST) and certain myelodysplastic/myeloproliferative diseases. By blocking the ATP-binding site of these kinases, imatinib prevents the phosphorylation of downstream signaling proteins, thereby inhibiting cell proliferation and inducing apoptosis in cancer cells that rely on these pathways for growth and survival. Its introduction revolutionized the treatment of CML, significantly improving patient outcomes.

Uses

• Treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST).
• Treatment of myelodysplastic/myeloproliferative diseases (MDS/MPD).

Directions For Use

Take orally with a meal and a large glass of water to minimize gastrointestinal irritation. Dosage varies based on the condition being treated and patient tolerance.

Benefits

• Highly effective in treating CML and GIST.
• Significantly improves survival rates in CML.
• Targets specific cancer-driving pathways.
• Oral administration for convenience.
• Reduces tumor burden and disease progression.
• Well-established safety profile for long-term use.

Side Effects

• Fluid retention (edema, especially periorbital)
• Nausea
• Vomiting
• Diarrhea
• Muscle cramps
• Fatigue
• Rash
• Myelosuppression (anemia, neutropenia, thrombocytopenia)
• Hepatotoxicity (liver damage)
• Cardiac dysfunction (rare)
• Hypothyroidism
• Headache

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase the risk of liver toxicity, a known side effect of imatinib.
• Pregnancy - Contraindicated due to potential for fetal harm. Women of childbearing potential must use effective contraception.
• Breastfeeding - Not recommended as imatinib is excreted in breast milk and could cause serious adverse effects in the infant.
• Liver - Use with caution in patients with hepatic impairment; dosage adjustments may be necessary. Monitor liver function closely.
• Kidney - Use with caution in patients with renal impairment; dosage adjustments may be required. Monitor kidney function.
• Lung - Can rarely cause interstitial lung disease or pulmonary hypertension; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.